434 related articles for article (PubMed ID: 16449486)
1. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.
Grant JE; Potenza MN; Hollander E; Cunningham-Williams R; Nurminen T; Smits G; Kallio A
Am J Psychiatry; 2006 Feb; 163(2):303-12. PubMed ID: 16449486
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
Grant JE; Kim SW; Hartman BK
J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
[TBL] [Abstract][Full Text] [Related]
3. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
Hollander E; Pallanti S; Allen A; Sood E; Baldini Rossi N
Am J Psychiatry; 2005 Jan; 162(1):137-45. PubMed ID: 15625212
[TBL] [Abstract][Full Text] [Related]
4. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.
Kim SW; Grant JE; Adson DE; Shin YC
Biol Psychiatry; 2001 Jun; 49(11):914-21. PubMed ID: 11377409
[TBL] [Abstract][Full Text] [Related]
5. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study.
Grant JE; Odlaug BL; Potenza MN; Hollander E; Kim SW
Br J Psychiatry; 2010 Oct; 197(4):330-1. PubMed ID: 20884959
[TBL] [Abstract][Full Text] [Related]
6. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.
Pallanti S; Baldini Rossi N; Sood E; Hollander E
J Clin Psychiatry; 2002 Nov; 63(11):1034-9. PubMed ID: 12444818
[TBL] [Abstract][Full Text] [Related]
7. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study.
Grant JE; Kim SW; Odlaug BL
Biol Psychiatry; 2007 Sep; 62(6):652-7. PubMed ID: 17445781
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania.
Grant JE; Kim SW; Odlaug BL
Biol Psychiatry; 2009 Apr; 65(7):600-6. PubMed ID: 19217077
[TBL] [Abstract][Full Text] [Related]
9. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling.
Grant JE; Kim SW; Hollander E; Potenza MN
Psychopharmacology (Berl); 2008 Nov; 200(4):521-7. PubMed ID: 18581096
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
McElroy SL; Nelson EB; Welge JA; Kaehler L; Keck PE
J Clin Psychiatry; 2008 Mar; 69(3):433-40. PubMed ID: 18251624
[TBL] [Abstract][Full Text] [Related]
11. Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys.
Slutske WS
Am J Psychiatry; 2006 Feb; 163(2):297-302. PubMed ID: 16449485
[TBL] [Abstract][Full Text] [Related]
12. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
13. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study.
Kim SW; Grant JE; Potenza MN; Blanco C; Hollander E
Psychiatry Res; 2009 Mar; 166(1):76-84. PubMed ID: 19200607
[TBL] [Abstract][Full Text] [Related]
14. Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
Black DW; Arndt S; Coryell WH; Argo T; Forbush KT; Shaw MC; Perry P; Allen J
J Clin Psychopharmacol; 2007 Apr; 27(2):143-50. PubMed ID: 17414236
[TBL] [Abstract][Full Text] [Related]
15. Opioid antagonists in broadly defined behavioral addictions: a narrative review.
Piquet-Pessôa M; Fontenelle LF
Expert Opin Pharmacother; 2016; 17(6):835-44. PubMed ID: 26798982
[TBL] [Abstract][Full Text] [Related]
16. Short-term single-blind fluvoxamine treatment of pathological gambling.
Hollander E; DeCaria CM; Mari E; Wong CM; Mosovich S; Grossman R; Begaz T
Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
[TBL] [Abstract][Full Text] [Related]
17. A Randomised, Double-Blind, Placebo-Controlled Trial of As-Needed Naltrexone in the Treatment of Pathological Gambling.
Kovanen L; Basnet S; Castrén S; Pankakoski M; Saarikoski ST; Partonen T; Alho H; Lahti T
Eur Addict Res; 2016; 22(2):70-9. PubMed ID: 26339899
[TBL] [Abstract][Full Text] [Related]
18. Opioid antagonists in the treatment of impulse-control disorders.
Kim SW
J Clin Psychiatry; 1998 Apr; 59(4):159-64. PubMed ID: 9590665
[TBL] [Abstract][Full Text] [Related]
19. An open-label study of naltrexone in the treatment of kleptomania.
Grant JE; Kim SW
J Clin Psychiatry; 2002 Apr; 63(4):349-56. PubMed ID: 12000210
[TBL] [Abstract][Full Text] [Related]
20. An open naltrexone treatment study in pathological gambling disorder.
Kim SW; Grant JE
Int Clin Psychopharmacol; 2001 Sep; 16(5):285-9. PubMed ID: 11552772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
